Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11131)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 26, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Löhn M, Plettenburg O, Kannt A, Kohlmann M, Hofmeister A, Kadereit D, Monecke P, Schiffer A, Schulte A, Ruetten H, Ivashchenko Y. End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899. World J Cardiol 2015; 7(1): 31-42 [PMID: 25632317 DOI: 10.4330/wjc.v7.i1.31] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v7/i1/31.htm |
| Number | Citing Articles |
| 1 |
William H. Nugent, Nikita Mishra, Jerome F. Strauss, Scott W. Walsh. Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1. Reproductive Sciences 2016; 23(4): 542 doi: 10.1177/1933719115607998
|
| 2 |
Tilahun Ayane Debele, Zachary F. Mount, Yong Yuan, Winston W.-Y. Kao, Yoonjee C. Park. The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells. Translational Vision Science & Technology 2023; 12(12): 4 doi: 10.1167/tvst.12.12.4
|
| 3 |
Alan R. Parrish. The cytoskeleton as a novel target for treatment of renal fibrosis. Pharmacology & Therapeutics 2016; 166: 1 doi: 10.1016/j.pharmthera.2016.06.006
|
| 4 |
Ghadeer Al-Humimat, Ibtisam Marashdeh, Duaa Daradkeh, Karanjit Kooner. Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma. Journal of Experimental Pharmacology 2021; : 197 doi: 10.2147/JEP.S259297
|
| 5 |
Yuto Yasuda, Lu Wang, Pasquale Chitano, Chun Y. Seow. Rho-Kinase Inhibition of Active Force and Passive Tension in Airway Smooth Muscle: A Strategy for Treating Airway Hyperresponsiveness in Asthma. Biology 2024; 13(2): 115 doi: 10.3390/biology13020115
|
| 6 |
R Jay Widmer, Lilach O Lerman, Amir Lerman. The Rho(ad)-kinase for individualized treatment of vasospastic angina. European Heart Journal 2018; 39(11): 960 doi: 10.1093/eurheartj/ehx757
|
| 7 |
David Mondaca-Ruff, Patricio Araos, Cristián E. Yañez, Ulises F. Novoa, Italo G. Mora, María Paz Ocaranza, Jorge E. Jalil. Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension. Journal of Cardiovascular Pharmacology and Therapeutics 2021; 26(6): 724 doi: 10.1177/10742484211053109
|
| 8 |
Yangbo Feng, Philip V. LoGrasso, Olivier Defert, Rongshi Li. Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential. Journal of Medicinal Chemistry 2016; 59(6): 2269 doi: 10.1021/acs.jmedchem.5b00683
|
| 9 |
Chunying Luo, Maxwell Ampomah-Wireko, Huanhuan Wang, Chunli Wu, Qing Wang, Hui Zhang, Yaquan Cao. Isoquinolines: Important Cores in Many Marketed and Clinical Drugs. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(7): 811 doi: 10.2174/1871520620666200424132248
|
| 10 |
Maria P. Ocaranza, Camila Fierro, Jorge E. Jalil, Jackeline Moya, Leticia Gonzalez, Cristián Molina, Cristián Mancilla. Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling. Clinical Science 2018; 132(16): 1837 doi: 10.1042/CS20180312
|